Marinomed receives € 6 m with final tranche of financing agreement with EIB to invest in proprietary R&D pipeline

AiCuris and Hybridize Therapeutics enter worldwide license agreement of up to €100M for a direct-acting RNA-based therapy against BK Virus

Lindis Blood Care successfully closes follow-on financing round

Abivax to host Satellite Symposium at the 17th Congress of ECCO on Feb. 17, 2022

Destiny Pharma: Positive feedback from European Medicines Agency on XF-73 Nasal gel Phase 3 programme

InflaRx to Present at Annual SVB Leerink Global Health Conference

Diaccurate appoints Laurence Riot Lamotte as Chief Financial Officer

iOmx Therapeutics Appoints Dr. Murray Yule as CMO to Lead Clinical Development

Rentschler Biopharma further strengthens Company Leadership Team

Galapagos appoints Paul Stoffels as Chief Executive Officer